Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with migraine, cluster headache, or tension-type headache according to Chinese medical guidelines (2022 editions)
- People aged 7 to 20 years old
- People who have had headaches on between 3 and 15 days per month in the past
- People who have been on a stable dose and frequency of their current medications and are not starting any new medications during the trial
- People who are willing to take part voluntarily and have signed a consent form
Who may not be able to join:
- People with a history of headaches caused by another condition, brain aneurysm, bleeding in the brain, brain tumour, severe head injury, drug abuse or addiction, fainting episodes, or seizures
- People who have previously had surgery to prevent migraines, a procedure to cut the vagus nerve in the neck, or have had an electronic nerve stimulation device implanted
- People currently using other electrical stimulation devices, such as TENS machines or muscle stimulators
- People who have an implanted medical device, such as a pacemaker, hearing aid, or any other implanted electronic device
- People who have had a nerve block in the head or neck area within the past 2 months
- People who use opioid pain medicines more than 2 days per month; use pain relievers or anti-inflammatory medicines alone more than 15 days per month; or use certain medicines including tamoxifen, ergot-based medicines, or combination pain relievers more than 10 days per month
- People who have had a cervical vagus nerve cutting procedure (confirm with trial site, as this appears to overlap with an earlier criterion)
- Children under 6 years old, or people who are pregnant
- People with significantly high or low blood pressure, or an abnormally slow or fast heart rate
- People with congenital heart disease (a heart condition present from birth)
- People with mental health or cognitive (thinking and memory) disorders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ji Ya-Bin, post-doc, Nanfang Hospital, Southern Medical University
Phone: +8613425122570
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reduction in pain intensity--actue period study
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.